SPONSOR

Emory University

Total Trials

Recruiting

Phases

Phase 1, Phase 2, Phase 4

Conditions studied: Breast Carcinoma Depression Advanced Lung Non-Small Cell Carcinoma Metastatic Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Solid Tumor Diabetic Foot Ulcer Osteosarcoma Recurrent

Emory University is a clinical research sponsor with 34 registered studies on ClinicalTrials.gov, of which 34 are actively recruiting participants. Research covers conditions including Breast Carcinoma, Depression, Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma.

The trial portfolio spans Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Emory University

How many clinical trials has Emory University sponsored?

ClinicalMetric currently tracks 34 clinical trials sponsored by Emory University, of which 34 are actively recruiting participants. These trials cover conditions including Breast Carcinoma, Depression, Advanced Lung Non-Small Cell Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Emory University research focus on?

Emory University clinical trials span Breast Carcinoma, Depression, Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Emory University clinical trial?

To participate in a Emory University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Emory University trials with current recruitment status updated daily.

Emory University

Frequently Asked Questions — Emory University

Clinical Trials by Emory University

Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya

Brain Stimulation and Decision-making

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation

Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)

Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors

Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Efficacy and Sustainability of a Carepartner-Integrated Telerehabilitation Program for Persons With Stroke

A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial

Effects of Lung Volume on Upper Airway Patency During Drug Induced Sleep Endoscopy

Heart Rate Variability and Inflammatory Bowel Disease

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

Sympathetic Overactivity in Post-traumatic Stress Disorder

Healthy Baby Healthy Mother Toolkit

Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

A Web-Based Dyadic Intervention for Colorectal Cancer

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

Progesterone in Gender Affirming Hormone Therapy Study

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

Health Behavior Intervention for Adults With Type 1 Diabetes

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Comprehensive Toileting Program

Bone Marrow and Peripheral Blood Immune Responses Study

CCSH (Compassion-Centered Spiritual Health) for Teams

Immune Monitoring and Assay Development in Organ Transplant Recipients

Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)